Analyst Ratings for Autolus Therapeutics plc (AUTL)
AUTL Rating Summary
AUTL Price Target Summary
- Highest: $11.00 (Needham)
- Lowest: $5.00 (Wells Fargo)
- Average: $8.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.07 (+385.9%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Avg. $ Target:
$8.07 (+385.9%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/17/2026 | H.C. Wainwright » Updated 4/30/2026 |
Emily Bodnar | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.40 (1.66) |
18.57% | Details |
| 11/18/2024 | Goldman Sachs » Updated 5/15/2026 |
Graig Suvannavejh | Upgrade | Buy (Neutral) |
5.40 (6.10) |
3.08 (1.66) |
-46.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
